RnD & INNOVATION
Innovation driven
Leading high-quality development
Taienkang’s parent company has three R&D bases, which are respectively Shandong Hubble Kisen Biological Technology Co., Ltd., Bochuangyuan (BCY) Pharm Co., Ltd., and Sichuan Checo Pharmaceutical Technology Co., Ltd. Meanwhile, the company also cooperates closely with experts from well-known university or scientific research institutions in China, including Sichuan University and Chengdu Institute of Biology of the Chinese Academy of Sciences. The R&D team is composed of researchers with Ph.D. and masters academic background, as well as rich experience, such as extensive experience in the industry. There are multiple innovative and scarce talents in the team with strong capability and expertise in various reactions. They can complete product research and development in the fields of chemical pharmaceuticals and bio-pharmaceuticals with high-quality and high-efficiency.
The R&D center is equipped with the state-of-the-art equipment and instruments, enabling us to achieve product process development, analytical method development, quality studies, etc. The production capability ranges from grams to kilograms level in the laboratory.
The company has always prioritized research and development of competitive products, and will continue to increase investment in innovation for the future.
R&D Capabilities
R&D Team:
180
+
Shandong Hubble Kisen
10
+
Bochuangyuan (BCY)
20
+
Sichuan Checo
Technical skills
nitration reaction, chiral synthesis, coupling reaction, halogenation reaction, Grignard reaction, high temperature and deep cold (-100 ℃ to 250 ℃) reaction, crystallization process development, etc.
Nitration Reaction
Chiral Synthesis
Coupling Reaction
Halogenation Reaction
Grignard Reaction
High Temperature and Deep Cold (-100 ℃ to 250 ℃) Reaction
Crystallization Process Development
Manufacturing Site
The company's manufacturing site is located in the provincial-level chemical industry zone of Yuechi County, Guang'an City, Sichuan Province. The factory covers an area of 66,745 square meters, with a building area of 50,000 square meters. It plans to build 6 multi-functional production workshops. Phase I of construction has been completed with a total of 4 production lines and 1 D-level GMP workshop, as well as 47 reactors (500L~5000L). It is designed to cooperate with clients to land projects ranging from laboratory R&D to commercial supply. The factory is built strictly in compliance with cGMP standards and has established a comprehensive quality management system. It is expected to pass authority audits such as the FDA, PMDA and EMA in the near future.
Total Land Area
66,745 square meters
Total Construction Area
50,000 square meters
Workshops
6 multifunctional production workshops
Phase I:4 production lines 1 D-level GMP workshop 47 reaction vessels
Reactor Volume:500L~5000L
Production Capacity
300 MT/year
Facilities and Equipment
We have the state-of-the-art facilities and equipment that are constantly being upgraded to meet the international dynamic market requirements.
Accreditations
It is expected to pass the China GMP compliance inspection in mid 2024 and prepare to accept more authority audits in the near future.